Cargando…

Safety & effectiveness of COVID-19 vaccines: A narrative review

There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use Authorization by the WHO that can offer some protection to the world’s population during the COVID-19 pandemic. Though research is being published all over the world, public health officials, policymakers and gove...

Descripción completa

Detalles Bibliográficos
Autores principales: Chirico, Francesco, da Silva, Jaime A. Teixeira, Tsigaris, Panagiotis, Sharun, Khan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552389/
https://www.ncbi.nlm.nih.gov/pubmed/35859436
http://dx.doi.org/10.4103/ijmr.IJMR_474_21
_version_ 1784806240199639040
author Chirico, Francesco
da Silva, Jaime A. Teixeira
Tsigaris, Panagiotis
Sharun, Khan
author_facet Chirico, Francesco
da Silva, Jaime A. Teixeira
Tsigaris, Panagiotis
Sharun, Khan
author_sort Chirico, Francesco
collection PubMed
description There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use Authorization by the WHO that can offer some protection to the world’s population during the COVID-19 pandemic. Though research is being published all over the world, public health officials, policymakers and governments are collecting evidence-based information to establish the public health policies. Unfortunately, continued international travel, violations of lockdowns and social distancing, the lack of mask use, the emergence of mutant strains of the virus and lower adherence by a sector of the global population that remains sceptical of the protection offered by vaccines, or about any risks associated with vaccines, hamper these efforts. Here we examine the literature on the efficacy, effectiveness and safety of COVID-19 vaccines, with an emphasis on select categories of individuals and against new SARS-CoV-2 strains. The literature shows that these eight vaccines are highly effective in protecting the population from severe disease and death, but there are some issues concerning safety and adverse effects. Further, booster shots and variant-specific vaccines would also be required.
format Online
Article
Text
id pubmed-9552389
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-95523892022-10-12 Safety & effectiveness of COVID-19 vaccines: A narrative review Chirico, Francesco da Silva, Jaime A. Teixeira Tsigaris, Panagiotis Sharun, Khan Indian J Med Res Review Article There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use Authorization by the WHO that can offer some protection to the world’s population during the COVID-19 pandemic. Though research is being published all over the world, public health officials, policymakers and governments are collecting evidence-based information to establish the public health policies. Unfortunately, continued international travel, violations of lockdowns and social distancing, the lack of mask use, the emergence of mutant strains of the virus and lower adherence by a sector of the global population that remains sceptical of the protection offered by vaccines, or about any risks associated with vaccines, hamper these efforts. Here we examine the literature on the efficacy, effectiveness and safety of COVID-19 vaccines, with an emphasis on select categories of individuals and against new SARS-CoV-2 strains. The literature shows that these eight vaccines are highly effective in protecting the population from severe disease and death, but there are some issues concerning safety and adverse effects. Further, booster shots and variant-specific vaccines would also be required. Wolters Kluwer - Medknow 2022-01 /pmc/articles/PMC9552389/ /pubmed/35859436 http://dx.doi.org/10.4103/ijmr.IJMR_474_21 Text en Copyright: © 2022 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Chirico, Francesco
da Silva, Jaime A. Teixeira
Tsigaris, Panagiotis
Sharun, Khan
Safety & effectiveness of COVID-19 vaccines: A narrative review
title Safety & effectiveness of COVID-19 vaccines: A narrative review
title_full Safety & effectiveness of COVID-19 vaccines: A narrative review
title_fullStr Safety & effectiveness of COVID-19 vaccines: A narrative review
title_full_unstemmed Safety & effectiveness of COVID-19 vaccines: A narrative review
title_short Safety & effectiveness of COVID-19 vaccines: A narrative review
title_sort safety & effectiveness of covid-19 vaccines: a narrative review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552389/
https://www.ncbi.nlm.nih.gov/pubmed/35859436
http://dx.doi.org/10.4103/ijmr.IJMR_474_21
work_keys_str_mv AT chiricofrancesco safetyeffectivenessofcovid19vaccinesanarrativereview
AT dasilvajaimeateixeira safetyeffectivenessofcovid19vaccinesanarrativereview
AT tsigarispanagiotis safetyeffectivenessofcovid19vaccinesanarrativereview
AT sharunkhan safetyeffectivenessofcovid19vaccinesanarrativereview